Vilgelm, Anna E.
Vanderbilt University · VA Tennessee Valley Healthcare System
3 papers on CoChatORCID 0000-0002-4446-913X
Most cited papers
- Verified
PI3K inhibition reduces mammary tumor growth and facilitates antitumor immunity and anti-PD1 responses
Sai, J., Owens, P., Novitskiy, S. V., Hawkins, O. E., Vilgelm, A. E., Yang, J., Sobolik, T., Lavender, N., Johnson, A. C., McClain, C., et al. (2017) · Clinical Cancer Research
PI3K/AKT/mTOR signaling in cancerCancer Immunotherapy and Biomarkers
Cited by 138
- Verified
Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells
Vilgelm, A. E., Pawlikowski, J. S., Liu, Y., Hawkins, O. E., Davis, T. A., Smith, J., Weller, K. P., Horton, L. W., McClain, C. M., Ayers, G. D., et al. (2015) · Cancer Research
Cancer-related Molecular PathwaysTelomeres, Telomerase, and Senescence
Cited by 115
- Verified
Connecting the dots: therapy-induced senescence and a tumor-suppressive immune microenvironment
Vilgelm, A. E., Johnson, C. A., Prasad, N., Yang, J., Chen, S.-C., Ayers, G. D., Pawlikowski, J. S., Raman, D., Sosman, J. A., Kelley, M., et al. (2016) · JNCI Journal of the National Cancer Institute
Cancer Immunotherapy and BiomarkersTelomeres, Telomerase, and Senescence
Cited by 95
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free